| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |